| 注册
首页|期刊导航|中医药信息|高血压前期的风险与干预策略研究进展

高血压前期的风险与干预策略研究进展

丁李立强 陈瑜 张腾

中医药信息2017,Vol.34Issue(2):111-116,6.
中医药信息2017,Vol.34Issue(2):111-116,6.

高血压前期的风险与干预策略研究进展

Risk and Interventive Strategies of Prehypertension

丁李立强 1陈瑜 1张腾2

作者信息

  • 1. 上海中医药大学附属岳阳中西医结合医院,上海200437
  • 2. 上海中医药大学附属岳阳医院中西医结合临床研究所,上海200437
  • 折叠

摘要

Abstract

Prehypertension is the blood pressure condition that is between normal blood pressure and hypertension.It is liable to develop into essential hypertension and increase the morbidity and mortality of cardiovascular diseases.Promoting active intervention and treatment for prehypertension can effectively prevent the incidence of hypertension and cardiovascular diseases.However,the choice of interventive methods for prehypertension remains controversial.In order to better understand the harm of prehypertension and the effect of traditional Chinese medicine and modern medicine on prehypertension,we review the prevalence of prehypertension,the incidence risk of progression to hypertension and cardiovascular diseases,lifestyle and medication interventions,and the effect of traditional Chinese medicine on preventing and treating prehypertension.

关键词

高血压前期/心血管疾病/中医药/治疗

Key words

Prehypertension/Cardiovascular diseases/Traditional Chinese medicine/Treatment

分类

医药卫生

引用本文复制引用

丁李立强,陈瑜,张腾..高血压前期的风险与干预策略研究进展[J].中医药信息,2017,34(2):111-116,6.

基金项目

上海市优秀学术带头人资助项目(No.1XD1403500) (No.1XD1403500)

国家自然科学基金面上项目(No.81273960,81473732) (No.81273960,81473732)

国家中医药管理局中西医结合临床重点学科建设项目(No.国中医药发[2009]30号) (No.国中医药发[2009]30号)

上海市高校特聘教授(东方学者)人才计划(No.沪教委人[2010]84号),沪教委人[No.2011]88号) (东方学者)

上海市浦江计划(No.11PJ1409000,13PJ1407800) (No.11PJ1409000,13PJ1407800)

上海市085一流学科建设科技创新支持计划(No.085ZY1212,085ZY1221) (No.085ZY1212,085ZY1221)

上海市曙光计划(No.13SG42) (No.13SG42)

中医药信息

1002-2406

访问量0
|
下载量0
段落导航相关论文